Virginia Retirement Systems’s Vir Biotechnology VIR Stock Holding History

Virginia Retirement Systems’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$242K	Sell	40,118 -15,850	-28%	-$94.4K	﹤0.01%	884
2025 Q3	$320K	Sell	55,968 -1,300	-2%	-$6.65K	﹤0.01%	837
2025 Q2	$289K	Sell	57,268 -3,900	-6%	-$20.9K	﹤0.01%	845
2025 Q1	$396K	Buy	+61,168	New	+$544K	﹤0.01%	816
2023 Q3	$533K	Buy	56,900 +17,000	+43%	+$242K	0.01%	678
2023 Q2	$979K	Sell	39,900 -3,200	-7%	-$80.4K	0.01%	555
2023 Q1	$1M	Buy	43,100 +18,600	+76%	+$476K	0.01%	547
2022 Q4	$620K	Buy	24,500 +5,700	+30%	+$140K	0.01%	771
2022 Q3	$362K	Buy	+18,800	New	+$478K	﹤0.01%	893

Other funds holding VIR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Virginia Retirement Systems's VIR Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Vir Biotechnology (VIR) stake by 28% in Q4 2025, selling an estimated $94.4K and leaving 40,118 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Virginia Retirement Systems first reported a position in VIR in Q3 2022 and has held it in 9 quarters since. The position peaked at $1M in Q1 2023. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

Virginia Retirement Systems held 40,118 shares of Vir Biotechnology worth $242K as of Q4 2025.
Virginia Retirement Systems sold 15,850 Vir Biotechnology shares in Q4 2025, an estimated $94.4K.
Vir Biotechnology made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #884 holding.
Virginia Retirement Systems first reported a position in Vir Biotechnology in Q3 2022 and has held it in 9 quarters since.
Virginia Retirement Systems's Vir Biotechnology position peaked at $1M in Q1 2023.
218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.